Literature DB >> 20358301

The clinical significance of vimentin-expressing gastric cancer cells in bone marrow.

Masaaki Iwatsuki1, Koshi Mimori, Takeo Fukagawa, Hideshi Ishii, Takehiko Yokobori, Mitsuru Sasako, Hideo Baba, Masaki Mori.   

Abstract

BACKGROUND: Expression of the mesenchymal marker gene vimentin (VIM) in gastric cancer is associated with a more aggressive form of the disease and poor prognosis. Because epithelial mesenchymal transition (EMT) plays a critical role in the progression of gastric cancer, VIM expression was examined in the bone marrow (BM) of gastric cancer patients.
METHODS: BM samples from 437 gastric cancer patients were collected and analyzed by quantitative RT-PCR. Expression of VIM protein in the primary lesions of resected gastric cancers was evaluated using immunohistochemistry. Furthermore, induction of VIM expression by TGF-beta1 and hypoxia was evaluated in gastric cancer cells.
RESULTS: VIM mRNA expression increased concordantly with clinical staging and was significantly associated with tumor invasion and lymph node metastasis (P < .0001). Though cancer cells in the primary lesions did not stain with VIM antibody, some of the cells invading the intratumoral vessels were strongly positive for VIM, but were negative for E-cadherin. Hypoxic conditions and treatment with TGF-beta1 induced VIM expression and repressed E-cadherin in gastric cancer cells, coupled with an alteration of cellular morphology.
CONCLUSIONS: We found that gastric cancer cells undergo EMT in BM to survive and metastasize. These findings suggest that isolated tumor cells have the potential to undergo EMT, which could increase the malignancy of gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20358301     DOI: 10.1245/s10434-010-1041-0

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  19 in total

Review 1.  Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets.

Authors:  Tamara Severi; Hannah van Malenstein; Chris Verslype; Jos F van Pelt
Journal:  Acta Pharmacol Sin       Date:  2010-10-18       Impact factor: 6.150

2.  Epithelial-mesenchymal transition expression profiles as a prognostic factor for disease-free survival in hepatocellular carcinoma: Clinical significance of transforming growth factor-β signaling.

Authors:  Kosuke Mima; Hiromitsu Hayashi; Hideyuki Kuroki; Shigeki Nakagawa; Hirohisa Okabe; Akira Chikamoto; Masayuki Watanabe; Toru Beppu; Hideo Baba
Journal:  Oncol Lett       Date:  2012-10-05       Impact factor: 2.967

3.  GANT-61 inhibits pancreatic cancer stem cell growth in vitro and in NOD/SCID/IL2R gamma null mice xenograft.

Authors:  Junsheng Fu; Mariana Rodova; Sanjit K Roy; Jay Sharma; Karan P Singh; Rakesh K Srivastava; Sharmila Shankar
Journal:  Cancer Lett       Date:  2012-11-28       Impact factor: 8.679

Review 4.  Biomarkers for predicting future metastasis of human gastrointestinal tumors.

Authors:  Lui Ng; Ronnie Tung Ping Poon; Roberta Pang
Journal:  Cell Mol Life Sci       Date:  2013-01-31       Impact factor: 9.261

5.  Clinical significance of vimentin expression and Her-2 status in patients with gastric carcinoma.

Authors:  Wenwen Zhao; Lu Yue; Fang Zhou; Congcong Xu; Wanhua Liang; Aihua Sui; Aiping Ding; Wensheng Qiu
Journal:  Clin Transl Sci       Date:  2013-04-19       Impact factor: 4.689

6.  Salvianolic acid B suppresses EMT and apoptosis to lessen drug resistance through AKT/mTOR in gastric cancer cells.

Authors:  Jie Wang; Yingze Ma; Min Guo; Haixia Yang; Xiaohui Guan
Journal:  Cytotechnology       Date:  2020-11-17       Impact factor: 2.058

Review 7.  The aberrant overexpression of vimentin is linked to a more aggressive status in tumours of the gastrointestinal tract.

Authors:  Marlena Brzozowa; Grzegorz Wyrobiec; Izabela Kołodziej; Mateusz Sitarski; Natalia Matysiak; Edyta Reichman-Warmusz; Małgorzata Żaba; Romuald Wojnicz
Journal:  Prz Gastroenterol       Date:  2015-01-14

8.  Differential Expression of ADAM23, CDKN2A (P16), MMP14 and VIM Associated with Giant Cell Tumor of Bone.

Authors:  André Luis Giacometti Conceição; Erica Babeto; Natalia Maria Candido; Fernanda Craveiro Franco; Débora Aparecida Pires de Campos Zuccari; Jane Lopes Bonilha; José Antônio Cordeiro; Marilia Freitas Calmon; Paula Rahal
Journal:  J Cancer       Date:  2015-05-23       Impact factor: 4.207

9.  TGF-β/Smad2/3 signaling directly regulates several miRNAs in mouse ES cells and early embryos.

Authors:  Nicholas Redshaw; Carme Camps; Vikas Sharma; Mehdi Motallebipour; Marcela Guzman-Ayala; Spyros Oikonomopoulos; Efstathia Thymiakou; Jiannis Ragoussis; Vasso Episkopou
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

10.  Hypoxia stimulates the EMT of gastric cancer cells through autocrine TGFβ signaling.

Authors:  Junko Matsuoka; Masakazu Yashiro; Yosuke Doi; Yuhiko Fuyuhiro; Yukihiro Kato; Osamu Shinto; Satoru Noda; Shinichiro Kashiwagi; Naoki Aomatsu; Toshiki Hirakawa; Tsuyoshi Hasegawa; Kiyoshi Shimizu; Toshiyuki Shimizu; Atsushi Miwa; Nobuya Yamada; Tetsuji Sawada; Kosei Hirakawa
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.